Recent progress in adjuvant discovery for peptide-based subunit vaccines

Article Properties
Cite
Azmi, Fazren, et al. “Recent Progress in Adjuvant Discovery for Peptide-Based Subunit Vaccines”. Human Vaccines &Amp; Immunotherapeutics, vol. 10, no. 3, 2013, pp. 778-96, https://doi.org/10.4161/hv.27332.
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2013). Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human Vaccines &Amp; Immunotherapeutics, 10(3), 778-796. https://doi.org/10.4161/hv.27332
Azmi F, Ahmad Fuaad AAH, Skwarczynski M, Toth I. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human Vaccines & Immunotherapeutics. 2013;10(3):778-96.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Medicine
Therapeutics
Pharmacology
Technology
Chemical technology
Biotechnology
Refrences
Title Journal Journal Categories Citations Publication Date
"Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.

 The Journal of Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 62 1992
Communications

 The Journal of Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 44 1968
Communications

 2010
Communications

 2009
Communications

 Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 1988
Citations
Title Journal Journal Categories Citations Publication Date
The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines

 Journal of Peptide Science
  • Science: Biology (General)
  • Science: Chemistry: Analytical chemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
In silico designing of novel epitope-based peptide vaccines against HIV-1 Biotechnology Letters
  • Technology: Chemical technology: Biotechnology
  • Science: Microbiology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
Research progress on emulsion vaccine adjuvants Heliyon 2024
Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine

 PLOS Computational Biology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Medicine: Medicine (General): Computer applications to medicine. Medical informatics
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents

 Pharmaceuticals
  • Medicine: Pharmacy and materia medica
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
Citations Analysis
Category Category Repetition
Medicine: Therapeutics. Pharmacology45
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy32
Medicine: Public aspects of medicine: Toxicology. Poisons32
Medicine: Medicine (General)30
Science: Chemistry29
Science: Biology (General)27
Technology: Chemical technology: Biotechnology24
Medicine19
Science: Chemistry: Organic chemistry: Biochemistry16
Science: Chemistry: General. Including alchemy15
Science: Chemistry: Analytical chemistry11
Science: Microbiology11
Technology: Chemical technology11
Science: Chemistry: Organic chemistry10
Science: Science (General)9
Medicine: Pharmacy and materia medica9
Medicine: Internal medicine: Infectious and parasitic diseases8
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials7
Science7
Medicine: Medicine (General): Medical technology4
Science: Biology (General): Genetics4
Science: Physics4
Technology: Chemical technology: Polymers and polymer manufacture3
Science: Biology (General): Cytology2
Science: Physiology2
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens2
Agriculture: Plant culture2
Agriculture: Animal culture2
Medicine: Pediatrics2
Science: Chemistry: Physical and theoretical chemistry1
Science: Physics: Atomic physics. Constitution and properties of matter1
Agriculture: Animal culture: Veterinary medicine1
Medicine: Medicine (General): Computer applications to medicine. Medical informatics1
Science: Botany1
Technology: Chemical technology: Chemical engineering1
Medicine: Internal medicine: Special situations and conditions: Arctic medicine. Tropical medicine1
Medicine: Public aspects of medicine1
Technology1
Technology: Engineering (General). Civil engineering (General)1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
The category Medicine: Therapeutics. Pharmacology 45 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Recent advances in peptide-based subunit nanovaccines and was published in 2014. The most recent citation comes from a 2024 study titled The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines. This article reached its peak citation in 2021, with 24 citations. It has been cited in 101 different journals, 28% of which are open access. Among related journals, the Vaccines cited this research the most, with 11 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year